Evidence map›Paper›PMID 16777166›Full record

ArticleVirology2006

Mapping the conformational epitope of a neutralizing antibody (AcV1) directed against the AcMNPV GP64 protein.

Jian Zhou, Gary W Blissard

Abstract read
In one paragraph

Article in Virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jian ZhouBoyce Thompson Institute, Cornell University, Tower Road, Ithaca, NY 14853, USA.
Gary W Blissard
Cornell University · US

Funding

FUNCTION OF THE BACULOVIRUS MEMBRANE FUSION PROTEINR01AI033657 · NIAID · BOYCE THOMPSON INST FOR PLANT RESEARCH · PI BLISSARD, GARY W · 1993 to 2009
$1.6M
Baculovirus envelope proteins and insect cellsR21AI033657 · NIAID · BOYCE THOMPSON INST FOR PLANT RESEARCH · PI BLISSARD, GARY W · 2004 to 2004
$189k
NIAID NIH HHS AI33657NIAID NIH HHS R01 AI033657NIAID NIH HHS R21 AI033657
6 · The paper itself

Abstract

The envelope glycoprotein GP64 of Autographa californica nucleopolyhedrovirus (AcMNPV) is necessary and sufficient for the acid-induced membrane fusion activity that is required for fusion of the budded virus (BV) envelope and the endosome membrane during virus entry. Infectivity of the budded virus (BV) is neutralized by AcV1, a monoclonal antibody (MAb) directed against GP64. Prior studies indicated that AcV1 recognizes a conformational epitope and does not inhibit virus attachment to the cell, but instead inhibits entry at a step following virus attachment. We found that AcV1 recognition of GP64 was lost upon exposure of GP64 to low pH (pH 4.5) and restored by returning GP64 to pH 6.2. In addition, the AcV1 epitope was lost upon denaturation of GP64 in SDS, but the AcV1 epitope was restored by refolding the protein in the absence of SDS. Using truncated GP64 proteins expressed in insect cells, we mapped the AcV1 epitope to a 24 amino acid region in the central variable domain of GP64. When sequences within the mapped AcV1 epitope were substituted with a c-Myc epitope and the resulting construct was used to replace wt GP64 in recombinant AcMNPV viruses, the modified GP64 protein appeared to function normally. However, an anti-c-Myc monoclonal antibody did not neutralize infectivity of those viruses. Because binding of the c-Myc MAb to the same site in the GP64 sequence did not result in neutralization, these studies suggest that AcV1 neutralization may result from a specific structural constraint caused by AcV1 binding and not simply by steric hindrance caused by antibody binding at this position in GP64.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionAnimalsAntibodies, ViralBase SequenceCell LineDNA, ViralEpitope MappingEpitopesGenes, mycHydrogen-Ion ConcentrationMothsMutagenesis, Site-DirectedNeutralization TestsNucleopolyhedrovirusesProtein ConformationAntibodies, ViralDNA, ViralEpitopesViral Structural Proteins

Identifiers

PMID16777166
PMCPMC3767133
OpenAlexW2017715727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.